Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis Article

Feng, Shu, Agoulnik, Irina U, Truong, Anne et al. (2010). Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis . ENDOCRINE-RELATED CANCER, 17(4), 1021-1033. 10.1677/ERC-10-0073

Open Access International Collaboration

cited authors

  • Feng, Shu; Agoulnik, Irina U; Truong, Anne; Li, Zhen; Creighton, Chad J; Kaftanovskaya, Elena M; Pereira, Rhea; Han, Hee Dong; Lopez-Berestein, Gabriel; Klonisch, Thomas; Ittmann, Michael M; Sood, Anil K; Agoulnik, Alexander I

sustainable development goals

authors

publication date

  • December 1, 2010

webpage

published in

keywords

  • ACTIVATION
  • ADENOCARCINOMA
  • CELL-ADHESION
  • CO-029
  • EXPRESSION
  • Endocrinology & Metabolism
  • H2 RELAXIN
  • Life Sciences & Biomedicine
  • MUC18
  • OVEREXPRESSION
  • Oncology
  • PROGRESSION
  • Science & Technology
  • TETRASPANINS

Digital Object Identifier (DOI)

publisher

  • BIOSCIENTIFICA LTD

start page

  • 1021

end page

  • 1033

volume

  • 17

issue

  • 4